Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus Medical Center, Dr Molewaterplein 40, 3015 CE, Rotterdam, The Netherlands.
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine, 100 Medical Plaza, Suite 310, Los Angeles, CA 90095, USA; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, VA Greater Los Angeles Healthcare System, 11301 Wilshire Blvd (111D), Los Angeles, CA 90073, USA.
Endocrinol Metab Clin North Am. 2022 Jun;51(2):403-416. doi: 10.1016/j.ecl.2021.11.021. Epub 2022 May 4.
Thyroid cancer is one of the most common cancers diagnosed in women of reproductive age and during pregnancy. This leads to important questions about thyroid cancer prognosis and treatment, but also fertility and risk for adverse obstetric and/or fetal and neonatal outcomes. The benefits of thyroid cancer treatment should be weighed against its harms, as various options may adversely impact maternal and fetal health. In the current review, the authors focus on perinatal-specific clinical considerations related to the care of patients with thyroid cancer.
甲状腺癌是生育年龄妇女和妊娠期最常见的癌症之一。这就引出了关于甲状腺癌预后和治疗的重要问题，也涉及到了生育能力以及不良产科和/或胎儿和新生儿结局的风险。甲状腺癌治疗的益处应该与危害相权衡，因为各种选择可能会对母婴健康产生不利影响。在本次综述中，作者重点关注与甲状腺癌患者护理相关的围产期特定临床注意事项。
